搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
1 小时
on MSN
This HIV drug is hailed as 2024's Discovery of the Year
A milestone was reached in the fight against HIV/AIDS with the development of Lenacapavir, a new injectable drug that ...
Impacts
4 小时
The Role of Recombinant Antibodies in Modern Drug Discovery
It is hard to overestimate the importance of antibodies in the frameworks of biotechnology and pharmaceutical industries.
2 小时
on MSN
Pfizer, Atavistik to collaborate on allosteric drug discovery
Pfizer (NYSE:PFE) has entered into a collaborative research agreement with Atavistik Bio for the discovery of novel precision ...
13 天
GenAI In Life Sciences: From Drug Discovery To The Nobel Prize
GenAI is generative, focusing on creating new content based on learned data, whether it’s text, images or molecular ...
4 天
on MSN
UAlbany professor works with AI firm on drug discovery research
Susan Sharfstein, a professor at UAlbany's College of Nanotechnology, Science and Engineering, partners with DeepSeq.AI on a ...
GEN
2 小时
Accelerating Bispecific Antibody Discovery: From Antigens to Lead Panels in Just Four Months
Invenra has launched its Rapid Antibody Discovery Service, designed to simplify and de-risk the preclinical development of ...
pharmaphorum
7 小时
Flagship-backed AI startup Valo shelves eye disease drug
The start-up – founded by investment group Flagship Pioneering – said that OPL-0401 did not meet either the primary or ...
13 天
on MSN
New synthesis technique cuts drug development time and cost
A team of chemists from Scripps Research and Rice University has unveiled a novel method to simplify the synthesis of ...
9 天
on MSN
Researchers develop tool to fast-track measurement of protein interactions for drug discovery
A team led by researchers at the University of Toronto has created a platform, called SIMPL2, that improves the study of ...
2 小时
Nano-Cap iBio Expands Obesity Program With New Antibody Using In-Licensed Platform
On Thursday, iBio, Inc. (NYSE:IBIO) expanded its cardiometabolic and obesity treatment development program by in-licensing a ...
2 天
Anthem Biosciences to go public with ₹3,395 crore IPO; focus on drug discovery and APIs
Indian contract drugmaker Anthem Biosciences files for $397 million IPO amid booming Indian market for public offerings.
当前正在显示可能无法访问的结果。
隐藏无法访问的结果
反馈